Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 15 of 31

COMPLETED NA

Reverse Shoulder Replacement: Formal vs. Home Physiotherapy

NCT03430167

COMPLETED

Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)

NCT03296592

TERMINATED NA

Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT

NCT03386227

COMPLETED NA

Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer

NCT03262831

TERMINATED Phase 1

Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma

NCT03267836

COMPLETED NA

A Novel Transition Program to Reduce Disability After Stroke

NCT03485820

COMPLETED Phase 1

Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach

NCT03346161

TERMINATED Phase 1

Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

NCT03122106

COMPLETED NA

A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair

NCT03450473

COMPLETED Phase 1

Implementation of a Nutritional Tool During Melphalan Autologous Transplant to Improve Caloric and Protein Intake

NCT03449927

COMPLETED NA

Intermittent Fasting in Multiple Sclerosis

NCT03539094

COMPLETED Phase 4

TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment

NCT03388268

COMPLETED NA

Cognitive Flexibility Training in Persistent Pain

NCT03398408

COMPLETED NA

Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients

NCT03473548

TERMINATED NA

Optimizing CRT With ECGI

NCT03492788

TERMINATED NA

Cap Assisted Upper Endoscopy Versus High Definition White Light Endoscopy and Narrow Band Imaging Alone In The Detection Of Visible Lesions Barrett's Esophagus: A Randomized Tandem Study

NCT03417570

TERMINATED

Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)

NCT03423407

COMPLETED

Measuring Bladder Volumes Scanning in the ICU

NCT03428113

COMPLETED Phase 2

A Study Examining the Medication Apremilast as Treatment for Chronic Itch

NCT03239106

COMPLETED NA

Text Based Mobile Technology and Weight Loss

NCT03203655

COMPLETED NA

MBSR in a Hispanic Immigrant Population in St. Louis

NCT03839589

COMPLETED

Impact of Component Design and Fixation in Total Knee Arthroplasty

NCT03272178

COMPLETED Phase 1

Remote Limb Ischemic Conditioning to Enhance Learning and Muscle Strength in Healthy Young Adults

NCT03512028

TERMINATED

How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes

NCT03370861

COMPLETED Phase 2

Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma

NCT03141034

COMPLETED Phase 1

Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response

NCT02797184

COMPLETED Phase 1

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

NCT03068819

TERMINATED NA

Providing Patients Realistic Expectations of Postoperative Pain

NCT03434847

COMPLETED NA

SMART Africa (Strengthening Mental Health Research and Training)

NCT03081195

COMPLETED NA

Prospective Memory Training in Parkinson Disease

NCT03582670

COMPLETED NA

Helping Empower Liver and Kidney Patients

NCT03426787

COMPLETED Phase 1

Lidocaine for Oxaliplatin-induced Neuropathy

NCT03254394

TERMINATED NA

Fluorescence Imaging in Head and Neck Cancer

NCT03297957

COMPLETED

Reducing Rural Colon Cancer Disparities

NCT03457454

COMPLETED NA

Pilot Study to Improve Medication Management in Older Adults

NCT04709640

COMPLETED NA

Novel Approach To Improving Lactation Support With Mobile Health Technology

NCT03332108

TERMINATED

Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use

NCT03248765

COMPLETED Phase 1

Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap

NCT03317470

COMPLETED

Human CNS Tau Kinetics in Tauopathies

NCT03545126

COMPLETED NA

Supporting and Enhancing NICU Sensory Experiences (SENSE)

NCT03316547

COMPLETED NA

Palliative Care in the ICU

NCT03263143

COMPLETED NA

Physical Therapy and Deep Brain Stimulation in Parkinson Disease

NCT03181282

COMPLETED Phase 1

Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

NCT03072771

COMPLETED NA

Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema

NCT03271034

TERMINATED Phase 4

Predictors of AAA Expansion and/or Rupture

NCT03231397

COMPLETED

Minimal Residual Disease in Peripheral T-cell Lymphoma

NCT03297697

COMPLETED NA

Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial

NCT03052920

COMPLETED Phase 1

Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy

NCT03213249

COMPLETED

Rad Predictors for WON

NCT03801070

TERMINATED Phase 2

Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia

NCT03063203

← Previous Page 15 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.